Female Stress Urinary Incontinence Treatment Devices Market Share

North American Market Forecast   

North America industry is likely to dominate majority revenue share of 42% by 2037. The growth of the market can be attributed majorly to the well-established healthcare infrastructure boosted by investment and growing R&D of drugs and medications. The healthcare spending of the U.S. in 2020 was USD 4000 billion. Furthermore, growing cases of stress urinary incontinence in the region owing to several regions backed by the presence of female stress urinary incontinence treatment device manufacturers are expected to expand the market size during the forecast period. Stress urinary incontinence is a disease that requires immediate medical attention. For instance, approximately 22 million American suffer from stress urinary incontinence and around 80% of them are women. Additionally, in every 3 women in the region, 1 of them has faced SUI in her life. Hence, all these factors are estimated to propel the growth of the market over the forecast period.

APAC Market Statistics

Furthermore, the Asia Pacific region is anticipated to obtain the second-largest share of the market during the forecast period. The growth of the market is attributed to the increased prevalence of overactive bladder and urinary incontinence among women in urban and rural settings, decreased access to adequate healthcare services, a decreased propensity to seek treatment, growing awareness of the various diagnostic and treatment options, and rising preference for minimally invasive treatments for Urinary Incontinence.